# LAST DAY TO INVEST - TODAY | One Health Biosensing

- Canonical URL: https://wefunder.com/feed/181978
- Entity ID: wefunder:feed_item:181978
- Published at: 2025-04-29 15:27:26 UTC
- Updated at: 2025-07-16 22:25:02 UTC

## Author
Jeff Dachis

## Subject
One Health Biosensing

## Content
TODAY ONLY - INVEST HERE: (https://wefunder.com/onehealthbiosensing).Family, friends and colleagues,Until now, we’ve funded everything internally. But we believe it’s the right time to invite outside investors to join us as we prepare for FDA submission and a commercial launch. After more than a decade of support from the global diabetes community, we want to return the favor by making a small portion of shares in One Health Biosensing available via WeFunder. If you’re interested, this is the final opportunity for community members and we’d love to have you on board as a community investor—no matter the amount—for which we hope to deliver you a meaningful potential return.Think of One Health Biosensing as the next step in our journey to improve the lives of every person on the planet with diabetes. With over ten years of research and development—including microneedle-based sensing arrays, AI-driven insights, groundbreaking electrochemistry and microelectronics, and multiple patents—we didn’t invent continuous glucose monitoring, but we are redefining it. It’s real, it’s happening now, and we couldn’t be more excited. Its also really cool. : )We’ve finalized our design, are already manufacturing product, have a large portfolio of awarded and pending patents, have accumulated over 1,600 on-body clinic hours, and conducted extensive market testing through third-party research and freedom-to-operate studies. Why does this matter? Because more than 95% of people with diabetes still don’t have access to a CGM they can afford. Current solutions from Dexcom, Abbott, and Medtronic primarily serve a smaller niche of people with Type 1 diabetes on intensive insulin management—leaving the vast majority of people with Type 2 without accessible options. Until now.We’re changing that by creating an ultra-low-cost, daily-dosed CGM powered by AI-enabled lifestyle insights. We designed it to be beautiful, accurate, flexible, and user-first, so everyone with diabetes can take control of their health. We’re targeting a product launch in 2026, and there is a lot to do before then.We didn’t invent CGM, but we are re-defining it.TODAY ONLY - INVEST HERE: (https://wefunder.com/onehealthbiosensing). The future of diabetes care is with One Health Biosensing. Please reach out if you’d like to connect or learn more.In good health and warm regards,Jeff Dachis CEO, Chairman, Founder One Health BiosensingFollow us here:Instagram: https://instagram.com/onehealthbiosensing/Facebook: https://facebook.com/profile.php?id=61566557262015LinkedIn: https://linkedin.com/company/one-health-biosensing/X/Twitter: https://x.com/OneHealthBioURL: https://onehealthbiosensing.com